frequent1, another good post here; thank you for sharing it - further evidence that Titan will not be trying to commercialize the Enos system, therefore Medtronic most likely will be the folks who do commercialize it. With Folks like Mr. Brar and Mr. Genova on board, development and protection of new technologies is an obvious strength to the organization and beyond Enos, that strength might be best utilized by a big company like Medtronic to improve their corporate offerings by developing more novel technologies for their new owners!
Message in reply to:
Just something to consider. We went from building a system and commercializing it, to just building a system, to now just building technologies? What exactly is the end game here? FDA approval for enos and then a buy out or just crank out and license "technologies" in the lab? I dont really care. Been invested here for about 4 years. Never sold. Still in the red by many many many many thousands. I'm sure you would understand why I'm cautiously optimistic. Good luck to us all.
November 01, 2019 3:29pm EDT
TORONTO--(BUSINESS WIRE)-- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery
January 27, 2020 8:28am EST
TORONTO--(BUSINESS WIRE)-- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery
June 04, 2020 7:30am EDT
TORONTO--(BUSINESS WIRE)-- Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies,
